IPP Bureau
Unichem gets 5 observations from USFDA for Goa formulation facility
By IPP Bureau - July 17, 2024
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Lupin divests US commercial women's health specialty business to Evofem
By IPP Bureau - July 17, 2024
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India
By IPP Bureau - July 17, 2024
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Avallano releases AI-driven ProtocolCopilot
By IPP Bureau - July 17, 2024
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols
Medix Biochemica appoints former Thermo Fisher Scientific Lonnie Shoff to its Board of Directors
By IPP Bureau - July 16, 2024
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
.jpg "Merck starts commercial production of first GMP-compliant manufacturing line for cell culture media in China")
Merck starts commercial production of first GMP-compliant manufacturing line for cell culture media in China
By IPP Bureau - July 16, 2024
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Merck completes acquisition of EyeBio
By IPP Bureau - July 16, 2024
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
ViiV Healthcare to announce data from largest head-to-head randomised clinical trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024
By IPP Bureau - July 16, 2024
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Suven Pharmaceuticals gets Form 483 from with two observations from USFDA for Casper Pharma
By IPP Bureau - July 14, 2024
The company will address these observations within the stipulated timeline
Alembic announces USFDA tentative approval for Selexipag for Injection, 1,800 mcg/vial
By IPP Bureau - July 14, 2024
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Veerhealth Care secures export order from US Institutional Supplier
By IPP Bureau - July 14, 2024
The company is planning to expand its plant capacity in in Vapi
Thermo Fisher Scientific completes acquisition of proteomics solutions company ‘Olink’
By IPP Bureau - July 14, 2024
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Piramal Pharma’s Ahmedabad facility completes USFDA PAI
By IPP Bureau - July 14, 2024
Health Minister Nadda reviews Ayushman Bharat PMJAY and Ayushman Bharat Digital Mission
By IPP Bureau - July 14, 2024
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
